Evidence into practice: Prescribing selective serotonin reuptake inhibitors

International Journal of Technology Assessment in Health Care

Volumn 14, Issue 2, 1998, Pages 387-391

  Freemantle, Nick ^a   Mason, James M ^a   Watt, Ian ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; EVIDENCE BASED MEDICINE; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE;

EID: 0031808713     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300012332     Document Type: Article

References (15)

1. Anonymous. Selective serotonin reuptake inhibitors for depression? Drug and Therapeutics Bulletin, 1993, 31, 57-58.
2. Bloor, K., Maynard, A. K., Freemantle, N. Lessons from international experience in controlling pharmaceutical expenditure, III: Regulating industry. British Medical Journal 1996, 313, 33-35.
3. Bogle, S. M., Harris, C. M. Measuring prescribing: The shortcomings of the item. British Medical Journal 1994, 308, 637-40.
4. Effective health care: Implementing clinical practice guidelines. Bulletin No 8. Leeds: University of Leeds, 1994.
5. Effective health care: The treatment of depression in primary care. Bulletin No. 5. Leeds: University of Leeds, 1993.
6. Freemantle, N., Grilli, R., Grimshaw, J., et al. Implementing the findings of medical research: The Cochrane Collaboration on Effective Professional Practice. Quality in Health Care, 1995, 4, 45-47.
7. Freemantle, N., Henry, D., Maynard, A., et al. Promoting cost-effective prescribing: Great Britian lags behind. British Medical Journal, 1995, 310, 955-56.
8. Freemantle, N., House, A., Song, F., et al. Selective serotonin reuptake inhibitor prescribing as a strategy for the prevention of suicide. British Medical Journal, 1994, 309, 249-53.
9. Harrison, G. New or old antidepressant? New is better. British Medical Journal, 1994, 309, 1280-81.
10. Ibbotson, S. L., Long, A. F., Sheldon, T. A., et al. An initial evaluation of Effective Health Care Bulletins as instruments of effective dissemination. Journal of Management in Medicine, 1993, 7, 48-57.
11. Jönsson, B., & Bebbington, P. E. What price depression? The cost of depression and the cost effectiveness of pharmacological treatment. British Journal of Psychiatry, 1994, 164, 665-73.
12. Montgomery, S. A., Henry, J., McDonald, G., et al. Selective serotonin reuptake inhibitors: Meta analysis of discontinuation rates. International Clinical Psychopharmacology, 1994, 9, 47-53.
13. Owens, D. Benefits of new drugs are exaggerated. British Medical Journal, 1994, 309, 1281-82.
14. Song, F., Freemantle, N., Sheldon, T. A., et al. Selection serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability. British Medical Journal, 1993, 306, 683-87.
15. World Health Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Classification Index. Oslo: World Health Organisation, 1992.